Fact CheckerSign in

NCT04663399Recruiting

IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy (IMPRESS)

IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy

Source: ClinicalTrials.gov · Last updated 23 Jan 2026

Brief summary (registry, in English)

IMPRESS study aims to describe the immuno-inflammatory and thrombo-inflammatory profiles during the first 24/36 hours of treatment of patients suffering from AIC treated with TM, and to study the possible impact of these profiles on the functional prognosis at 3 and 12 months of AIC treatment.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1200 (estimated)
First submitted
25 Nov 2020
Start date
23 Feb 2023
Primary completion date
23 May 2028
Lead sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Diseases
Stroke
NCT number
NCT04663399

What you commit to

  • Study type: Observational
  • Planned participants: 1200
  • From 23 Feb 2023 to the primary completion date, 23 May 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • None.

Who the study is looking for

  • Patient with an acute ischemic stroke for which treatment with mechanical thrombectomy is indicated, whether or not thrombectomy is performed,
  • Having received informed information about the study and having signed a consent to participate in the study (if this is not possible: information and consent of the trusted support person or family member if present; emergency inclusion if absent);
  • Affiliated or beneficiary of a social security scheme or equivalent.
    • Non inclusion Criteria:
  • Pregnant or breast-feeding women
  • Patient benefiting from a legal protection measure

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hopital Fondation Adolphe de Rothschild
Coordinator of this site? Confirm its status
ParisFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.